LETICIA PORIER: Open Payments
NPI 1295052207 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 50 payments from 14 companies in 2025. Trend: 2023 $25 · 2024 $329 · 2025 $1,391
Food & beverage: $1,391
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $240 |
| AstraZeneca Pharmaceuticals LP | 3 | $230 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $189 |
| Novo Nordisk Inc | 10 | $174 |
| Insulet Corporation | 3 | $162 |
| ABBVIE INC. | 7 | $149 |
| Exact Sciences Corporation | 4 | $76 |
| Amgen Inc. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Dexcom, Inc. | 1 | $20 |
Products named: Kerendia, OMNIPOD, KISUNLA, AIRSUPRA, UBRELVY, Wegovy, Ozempic, MOUNJARO.
Industry payments across TX — which companies pay providers there.
